Schulman Amy W is a director of SQZ Biotechnologies Co.
Person profile
Roles
Address
New York, New York
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Fractyl Health, Inc.
5 Feb 24
3
Fractyl Health, Inc.
1 Feb 24
4
SQZ Biotechnologies Co
15 Jun 23
4
ALNYLAM PHARMACEUTICALS, INC.
19 May 23
4
ALNYLAM PHARMACEUTICALS, INC.
27 Feb 23
4
SQZ Biotechnologies Co
16 Jun 22
4
ALNYLAM PHARMACEUTICALS, INC.
20 May 22
4
ALNYLAM PHARMACEUTICALS, INC.
25 Feb 22
4
SQZ Biotechnologies Co
23 Dec 21
4
SQZ Biotechnologies Co
15 Dec 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
14 Jun 23 | SQZB SQZ Biotechnologies | Stock Option Common Stock | Grant | Acquire A | No | No | 0.539 | 39,875 | 21.49 k | 39,875 |
18 May 23 | ALNY Alnylam Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 189.87 | 3,454 | 655.81 k | 3,454 |
23 Feb 23 | ALNY Alnylam Pharmaceuticals | Common Stock | Option exercise | Acquire M | No | No | 0 | 136 | 0.00 | 136 |
23 Feb 23 | ALNY Alnylam Pharmaceuticals | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 136 | 0.00 | 0 |